CYLENE PHARMACEUTICALS, INC.

Profile

Company Names

CYLENE PHARMACEUTICALS, INC.

Addresses

5820 NANCY RIDGE DRIVE, SUITE 200, SAN DIEGO, CA 92121

Phone Numbers

8588755100

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$16,502,924.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-01-08 
$867,000.00 
$1,000,000.00 
$133,000.00 
Debt 
1
2010-05-26 
$15,635,924.00 
$20,185,578.00 
$4,549,654.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
REINHARD 
J. 
AMBROS 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.   |  TOKAI PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC
REINHARD 
J. 
AMBROS, PH.D. 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.
PETER 
 
FEINSTEIN 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.   |  MOMELAN TECHNOLOGIES, INC.   |  FEINSTEIN GROUP, LLC   |  BIOVENTURES INVESTORS IV LIMITED PARTNERSHIP
SHAUN 
A. 
KIRKPATRICK 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.
FRED 
A. 
MIDDLETON 
DIRECTOR
ENDOCYTE INC   |  NOVOCELL, INC   |  CYLENE PHARMACEUTICALS, INC.   |  LINEAGEN INC   |  AXIKIN PHARMACEUTICALS INC   |  STEREOTAXIS, INC.   |  VIACYTE INC.   |  LINEAGEN, INC   |  CHIMERIX INC   |  MESA VERDE VENTURE PARTNERS IV, LP   |  THERAVIDA, INC.
ERICH 
 
PLATZER 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.   |  LOCUS PHARMACEUTICALS INC   |  BC PLATFORMS AG
ERICH 
 
PLATZER, M.D. 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.
WILLIAM 
G. 
RICE 
EXECUTIVE OFFICER, DIRECTOR
CYLENE PHARMACEUTICALS, INC.
WILLIAM 
G. 
RICE, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
CYLENE PHARMACEUTICALS, INC.
S. 
EDWARD 
TORRES 
DIRECTOR
TRINITY BIOSYSTEMS INC   |  CYLENE PHARMACEUTICALS, INC.   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  COHERUS BIOSCIENCES, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
DANIEL 
D. 
VON HOFF 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.
DANIEL 
D. 
VON HOFF, M.D., F.A.C.P. 
DIRECTOR
CYLENE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-01-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-01-08 
2011-08-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-26 
2010-06-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#